Immunotherapy plus chemo shows promise in shrinking HPV throat tumors before surgery
NCT ID NCT07290621
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2 trial is testing whether giving the immunotherapy drug toripalimab along with standard chemotherapy before surgery or radiation can shrink HPV16-positive oropharyngeal (throat) tumors by at least 50%. The study enrolls 30 patients with advanced but localized disease. After the drug combo, patients may have robotic surgery or a reduced-intensity chemoradiation plan based on how well the tumor responded.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- toripalimab (an immunotherapy drug) combined with carboplatin and paclitaxel (chemotherapy drugs)
- What this could lead to
- If successful, this could lead to a treatment approach that shrinks HPV-related throat cancer tumors significantly before surgery or radiation, potentially allowing for less intense follow-up therapy.
- What could go wrong
- This is a small, early-phase (Phase 2) trial with only 30 participants, so results may not apply to everyone. The drug combination may cause side effects, and it is not yet known if it improves long-term survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV16-POSITIVE OROPHARYNGEAL SQUAMOUS-CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Chicago Medicine Comprehensive Cancer Center
RECRUITINGChicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug combo targets HPV-Driven cancers in phase II trial
- New sedative could speed recovery for ventilator patients
- Can light be the new shield against radiation mouth sores?
- Could a common numbing drug help fight throat cancer?
- Could less radiation be better? new trial spares healthy neck tissue
- New hope for throat cancer patients: smarter treatments on the horizon